Theta Research
  • Home
  • Graph
  • CompaniesPro
  • Pulse
  • Shipped
  • Engine

For serious investors who think in systems.

AboutAbout
ToolsOption LabDashboard
FeedbackRoadmap
© 2026 theta.md
← Back to Events
COMPLETEDTier 2earnings-single

CoreWeave Q1 2026 Earnings — Debt Leverage vs Backlog Validation

2026-05-07 → 2026-05-07·7 companies·10 predictions·Brier: 0.152
?CRWVdirect?NVDAsupply-chain—MSFTsupply-chain—METAsupply-chain?APLDsupply-chain?NBIScompetitive—ANETsupply-chain

Scenario Comparison

Bull CaseS1
15%

Q1 revenue exceeds $2.0B (above guidance top), adj EBITDA margin >55%, RPO formally disclosed >$95B, Anthropic contract value revealed >$5B

↑ 4↓ 15 companies
+CRWVstrong
+NVDAmild
+APLDmoderate
−NBISmild
+1 more
Base CaseS6
35%

Management formally discloses Anthropic contract value during Q1 call — either >$5B (bull confirmation) or <$2B (bear signal that 'multibillion' framing was cosmetic)

↑ 3↓ 03 companies
+CRWVmoderate
+NVDAmild
+APLDmild
Bear CaseS5
10%

Q1 revenue <$1.75B or FY2026 guidance cut below $12B, EBITDA margin compression below 50%, potential credit watch or covenant waiver discussion

↑ 0↓ 55 companies
−CRWVstrong
−NVDAmoderate
−APLDstrong
−NBISmoderate
+1 more

All Scenarios

6

Positioning Suggestions

→ CRWV stock at $126 is ABOVE our $115 bear trigger (triggered 4/16) — do NOT add to position pre-earnings. The 75% YTD rally has priced in significant upside; risk-reward is asymmetric to the downside for a hold position

→ Consider protective put or collar strategy: implied move 18.71% with 3/4 recent miss rate argues for downside protection. The 72.2% average miss magnitude means a miss would not be mild

→ If Q1 beats and RPO >$95B disclosed: revisit $105 base case target — may need to shift anchor to FY2027E. But DO NOT chase above $140 (Jefferies PT is $160 but represents bull scenario pricing)

→ If Q1 misses: watch for APLD sympathy weakness — Polaris Forge counterparty risk narrative creates a buying opportunity if CRWV debt remains serviceable

→ NBIS position: if CoreWeave misses, monitor whether customer inquiry volume to NBIS accelerates (neocloud competitive rotation). If CoreWeave beats, NBIS faces the 'credibility bar raised' dynamic

Predictions

10
✓

CoreWeave Q1 2026 revenue meets or exceeds $1.97B analyst consensus

35%P1

If beat → hold position, reassess base case target upward toward $115-125

✓

CoreWeave Q1 2026 revenue meets or exceeds $1.9B guidance floor

70%P2

If miss → trim position 20-30%; debt spiral bear probability increases from 15% to 25%+

✓

CoreWeave formally reports RPO exceeding $90B at Q1 2026 earnings (including Meta/Anthropic additions)

60%P3

If confirmed → validates the deal-reprice math; anchors FY2027 bull case

✗

Anthropic contract value is formally disclosed during the Q1 earnings call or filing

40%P4

If disclosed >$5B → bull confirmation; if <$2B → credibility hit, consider trim

✓

Q1 adjusted operating income is positive (above $0M guidance floor)

55%P5

If negative → margin trough is deeper than guided; Q4 'low double digit' target at risk

✗

Q1 interest expense exceeds $590M (above the top of $510-590M guidance range)

20%P6

If exceeded → debt burden accelerating faster than modeled; bear thesis strengthens

✗

Microsoft revenue concentration reported below 60% for Q1 2026

25%P7

If achieved → major diversification inflection, de-risks the concentration bear case

✗

CRWV stock moves more than 15% in either direction within 2 trading days of the report

60%P8

If large move down → evaluate APLD sympathy weakness as potential entry point

✗

FY2026 full-year revenue guidance is raised above $13B

10%P9

If raised → rerate to bull scenario; recalculate probability-weighted target

✗

Management announces a new customer contract worth >$3B during the Q1 earnings call

10%P10

If announced → further concentration de-risking; RPO expansion accelerates beyond current model

Key Questions

  1. What is the formal pro-forma RPO including Meta $21B and Anthropic? Does it reach $90-95B as modeled?
  2. Will management disclose the Anthropic contract value? The >$5B/$<$2B threshold is a key thesis signal
  3. What is Q1 Microsoft revenue concentration? Has it declined from 67% toward the 50-55% target?
  4. What is the Q1 interest expense actual ($510-590M guided)? What is the run-rate trajectory for FY2026?
  5. Any update on OpenAI TX/NV computing region delivery timing (H1 2026 target)?
  6. What is Q1 adj EBITDA margin? Does it confirm the 'margin trough' narrative or show structural compression?
  7. Any commentary on GPU rental pricing trends (H100/B200/GB300) — is commoditization accelerating?
  8. Capex execution: is the $30-35B FY2026 plan on track? Any delays in data center construction or power sourcing?

Monitoring Checklist

0/12 checked

Post-Event Results

Brier Score0.152
correct4/10
Trade Actions6

Actual Outcomes

  • • Q1 revenue $2.078B — beat consensus ($1.97B) by 5.5% and exceeded guidance top ($2.0B), breaking CoreWeave's 3/4 recent-quarter miss pattern
  • • Revenue backlog (RPO) reached $99.4B — far exceeding the $90-95B modeled range; $40B in new customer commitments signed in Q1 alone
  • • Adjusted EBITDA $1.157B at 56% margin; adjusted operating income $21M positive (above $0M guidance floor, management said this is 'expected to be its low point')
  • • Interest expense $536M — within $510-590M guidance range, not breaching the top end
  • • Anthropic described as 'multibillion-dollar' contract but specific dollar value NOT formally disclosed; Anthropic among 10 customers now committed to $1B+ each
  • • Microsoft revenue concentration not explicitly disclosed for Q1 2026; FY2025 was 67%. Customer diversification highlighted qualitatively (10 customers at $1B+, non-investment-grade <30% of backlog) but no specific percentage improvement reported
  • • Q2 guidance $2.45-2.6B (mid $2.53B) — below consensus $2.69B, triggering the selloff despite Q1 beat. This was the primary driver of the negative stock reaction
  • • FY2026 revenue guidance maintained at $12-13B (not raised); exit run-rate floor raised to $18B. FY2026 adj OI guided $900M-$1.1B
  • • Capex $7.695B in Q1 (above $6-7B guide); FY2026 capex guided $31-35B (raised from $30-35B low end)
  • • CRWV stock: $128.84 close May 7 → $113.80 close May 8 (-11.68%); down ~10% in after-hours on guidance miss
  • • CEO Mike Intrator declared 'We have reached hyperscale'; 3.5 GW contracted power, surpassed 1 GW active
  • • Raised $8.5B in new debt in Q1; first investment-grade HPC-backed loan rated A- equivalent at sub-6% cost
  • • NBIS (Nebius) dropped -4.18% on May 8 in sympathy; Seeking Alpha flagged two warnings for NBIS from CoreWeave's results (growth without operating leverage is not enough)

Market Reaction

CRWV-11.7%NBIS-4.2%

Thesis Updates Needed

CRWV·Q1 revenue beat ($2.078B) breaks the 3/4 miss pattern, but Q2 guidance miss ($2.53B mid vs $2.69B consensus) and -11.68% selloff show market demands margin expansion, not just growth. RPO at $99.4B validates backlog but $115 bear trigger tested ($113.80 close). Exit run-rate raised to $18B floor is a new positive data point.
scenarioAnalysis.triggerConditionsriskscompetitivePosition
APLD·CoreWeave Q1 adj OI positive ($21M) and $99.4B RPO de-risk Polaris Forge counterparty concerns. CRWV financial health confirmed — APLD monitoring trigger (credit downgrade) did not fire.
risksscenarioAnalysis
NBIS·CoreWeave Q1 beat + $99.4B RPO raises competitive bar for neoclouds. NBIS -4.18% sympathy weakness on May 8. CoreWeave's runaway growth without operating leverage is a warning signal for NBIS's own margin trajectory.
competitivePositionscenarioAnalysis

Trade Recommendations

→ Prediction #1 confirmed (revenue beat $2.078B > $1.97B) → hold CRWV position; reassess base case upward. However, -11.68% selloff on Q2 guidance miss complicates the bullish read — market is repricing from 'revenue acceleration' to 'when does margin expand?'

→ Prediction #2 confirmed (above $1.9B floor) → no trim trigger; debt spiral probability remains at baseline 15%

→ Prediction #3 confirmed (RPO $99.4B > $90B) → validates deal-reprice math; FY2027 bull case anchored by massive backlog (75% recognizable within 4 years)

→ Prediction #4 not confirmed (Anthropic value undisclosed) → conditional trade void; 'multibillion' framing persists without dollar resolution

→ Prediction #8 not confirmed (stock -11.68%, not >15%) → APLD sympathy entry observation void

→ Key insight: stock sold off despite beating on every Q1 metric. This is a guidance-driven sell — $115 bear trigger tested ($113.80 close). Watch for hold or break in coming sessions